Results 221 to 230 of about 142,066 (310)

Exposure-Efficacy Meta-Model of Nintedanib in Adult Patients With Chronic Fibrosing Interstitial Lung Diseases. [PDF]

CPT Pharmacometrics Syst Pharmacol
Hartmann S, Janssen J, Ribbing J, Stowasser S, Korell J.   +4 more
europepmc   +1 more source

Real time in vivo efficacy monitoring of desialylation and perforation enhanced immunotherapy of cancer

BMEMat, EarlyView.
A multifunctional nanomedicine is designed to engineer NK cells for enhanced cancer immunotherapy through perforation and desialylation, enabling real‐time monitoring of ATP and GrB levels for precise efficacy assessment. Abstract Efficient enhanced NK cell therapy is of critical importance in the immune treatment of cancer.
Yuanjiao Yang, Yuru Wang, Xuemei Li, Chaoyi Yang, Yuhui Yang, Yanyun Fang, Lin Ding, Yunlong Chen, Huangxian Ju   +8 more
wiley   +1 more source

Neurocognitive Dysfunction in Fibrosing Interstitial Lung Diseases: A Multidimensional Analysis of Pulmonary, Cognitive, and Clinical Correlates. [PDF]

Diagnostics (Basel)
Vastag Z, Tudorache E, Traila D, Ciortea I, Fira-Mladinescu O, Oancea C, Bratosin F, Rosca EC.   +7 more
europepmc   +1 more source

Beyond wound sealing: A dual‐functional adhesive nanofiber membrane promoting coagulation and osteogenesis in extraction sites

BMEMat, EarlyView.
Inspired by the suction mechanics of octopus suckers, a dual‐layer nanofiber membrane integrates antibacterial protection, strong wet adhesion, and osteogenic support, offering a bioinspired strategy for effective hemostasis and alveolar bone preservation.
Huijing Ma, Liheng Gao, Hao Liang, Wentao Jiang, Junyi Wang, Jiajia Wang, Shuhan Duan, Lingxi Meng, Adilijiang Yimiti, Wenjie Zhang   +9 more
wiley   +1 more source

Pulmonary Amyloidosis as a Differential Diagnosis in Interstitial Lung Diseases. [PDF]

Open Respir Arch
Cabrera-Cesar E, Garcia JL, de Pedro IP.
europepmc   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source

A novel, non-spirometric "BMP index" for predicting severe adverse outcomes in fibrosing interstitial lung diseases. [PDF]

Sci Rep
Huang TH, Hou HY, Chang HY, Hu CH, Kuo HI, Er HP, Wu YW, Lin CY, Tseng YL, Wang JM, Huang LT, Weng CT, Lin SH, Shieh CC, Wu CL.   +14 more
europepmc   +1 more source

The ageing holobiont: crosstalk between telomere dynamics, oxidative stress and the gut microbiome

Biological Reviews, EarlyView.
ABSTRACT The gut tissue is at the frontline of early onset of ageing. It exhibits high cell turnover rates and rapid telomere shortening, which can have systemic effects on the developing or senescing organism. We conducted a literature review of studies on the crosstalk between telomere length dynamics, telomerase activity, oxidative stress, and gut ...
Michael L. Pepke, Søren B. Hansen, Morten T. Limborg   +2 more
wiley   +1 more source

Correction: Understanding emotional and practical challenges of initiating oxygen therapy in pulmonary fibrosis: insights from a patient-centered survey

BMC Pulmonary Medicine
Marjolein Drent, Lian Trapman, Miranda Hennevelt-Leenen, Jan C. Grutters, Anne-Marie Russell   +4 more
doaj   +1 more source

Pathophysiological Insights and Clinical Management Strategies for Interstitial Lung Diseases. [PDF]

Biomol Ther (Seoul)
Tian L, Wang Y, Qi W, Wang B, Zhang X, Gong M, Zhang X, Wang T.   +7 more
europepmc   +1 more source